SCHEMBL21883221

SCHEMBL21883221

S=C(Nc1c(Cl)cccc1Cl)n1cccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
PLAU P00749 2/20 0.41
ELANE P08246 2/20 0.41
F2 P00734 1/20 0.41
KLKB1 P03952 1/20 0.41
FBP1 P09467 1/20 0.41
TYK2 P29597 1/20 0.41
PDE4B Q07343 2/20 0.38
MAPK1 P28482 1/20 0.37
PTPN7 P35236 1/20 0.37
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN11 Q06124 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
GAA P10253 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
NOS1 P29475 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24221901 0.84 MAPT (0.46) MAPTPLAUELANEF2KLKB1
SCHEMBL21883267 0.83 ALDH1A1 (0.49) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL21883273 0.83 LMNA (0.51) MAPTGAAMEN1KMT2ALMNA
SCHEMBL21808058 0.81 ELANE (0.46) MAPTELANEFBP1GAALMNA
SCHEMBL21883217 0.78 FBP1 (0.47) MAPTPLAUELANEF2KLKB1
SCHEMBL21883137 0.77 SMN1; SMN2 (0.49) MAPTFBP1PDE4BMEN1KMT2A
SCHEMBL21883121 0.77 KMT2A (0.51) MAPTGAAMEN1KMT2ALMNA
SCHEMBL21883219 0.77 F2 (0.51) MAPTPLAUELANEF2KLKB1
SCHEMBL21883224 0.76 RAB9A (0.54) MAPTMAPK1GAAMEN1KMT2A
SCHEMBL21883233 0.75 GAA (0.38) MAPTTYK2MAPK1PTPN7DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2026-01-27 US disclosed
US-20220024877-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION THE UAB RESEARCH FOUNDATION 2022-01-27 US disclosed
US-20220024877-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION THE UAB RESEARCH FOUNDATION 2022-01-27 US disclosed
WO-2020061412-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2020-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection TST, SLC39A11, SLC39A3 MAPT 1521/4885PLAU 4376/4885ELANE 39/4885
US-20220024877-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION SLC39A11, CNBP, SLC39A3 MAPT 2375/4885PLAU 4121/4885ELANE 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.